Changes in monocyte/macrophage neurotoxicity in the era of HAART: implications for HIV-associated dementia - PubMed (original) (raw)
Changes in monocyte/macrophage neurotoxicity in the era of HAART: implications for HIV-associated dementia
Leonard Kusdra et al. AIDS. 2002.
Abstract
Objective: To determine changes in CD14/CD69 cells of HIV seropositive patients with HIV-1 associated dementia (HAD) on highly active antiretroviral therapy (HAART) and to determine the effect of soluble factors from cultured monocyte/macrophage (M/M phi) on neural cell functional proteins.
Design and methods: Whole blood from patients with HAD, HIV seronegative subjects, and HIV seropositive subjects with no dementia (HIV-ND) was analyzed for CD14/CD69 cells using flow cytometry. M/M phi were isolated and cultured, and supernatants tested for neurotoxicity. Modulation of neural cell proteins and mitogen-activated protein kinases in response to supernatant exposure was examined by Western blot.
Results: CD14/CD69 levels from HAART-treated HAD subjects were significantly elevated over those from HIV-ND subjects and controls. However, levels were significantly lower than those reported in similarly selected HAD subjects tested prior to the HAART era. Treatment of neural cells with M/M phi-derived culture supernatants from HAART-treated HAD subjects was not associated with cell death, but resulted in a trend towards lower activation of the JNK, AKT, and ERK kinases, decreased expression of SNAP-25, and increased expression of neurofilament light than was observed after treatment with HIV-ND M/M phi supernatants.
Conclusions: The clinical phenotype of HAD appears to be evolving from a subacute dementing disease to a more protracted disorder. Decreased CD14/CD69 levels may reflect changes in some aspects of the pathophysiology of brain injury in the era of HAART. Changes in neural cell signaling, structural and functional proteins may represent more subtle neurotoxicity, manifested in cell dysfunction rather than frank cell death.
Similar articles
- Loss of macrophage-secreted lysozyme in HIV-1-associated dementia detected by SELDI-TOF mass spectrometry.
Sun B, Rempel HC, Pulliam L. Sun B, et al. AIDS. 2004 Apr 30;18(7):1009-12. doi: 10.1097/00002030-200404300-00008. AIDS. 2004. PMID: 15096803 - Elevation of CD69+ monocyte/macrophages in patients with Alzheimer's disease.
Kusdra L, Rempel H, Yaffe K, Pulliam L. Kusdra L, et al. Immunobiology. 2000 May;202(1):26-33. doi: 10.1016/S0171-2985(00)80049-2. Immunobiology. 2000. PMID: 10879686 - Unique monocyte subset in patients with AIDS dementia.
Pulliam L, Gascon R, Stubblebine M, McGuire D, McGrath MS. Pulliam L, et al. Lancet. 1997 Mar 8;349(9053):692-5. doi: 10.1016/S0140-6736(96)10178-1. Lancet. 1997. PMID: 9078201 - Neurologic consequences of HIV infection in the era of HAART.
Sperber K, Shao L. Sperber K, et al. AIDS Patient Care STDS. 2003 Oct;17(10):509-18. doi: 10.1089/108729103322494302. AIDS Patient Care STDS. 2003. PMID: 14588091 Review. - HIV-associated dementia in the era of highly active antiretroviral therapy (HAART).
Xia C, Luo D, Yu X, Jiang S, Liu S. Xia C, et al. Microbes Infect. 2011 May;13(5):419-25. doi: 10.1016/j.micinf.2011.01.004. Epub 2011 Jan 22. Microbes Infect. 2011. PMID: 21262373 Review.
Cited by
- HIV-1 Tat induced microglial EVs leads to neuronal synaptodendritic injury: microglia-neuron cross-talk in NeuroHIV.
Kannan M, Singh S, Chemparathy DT, Oladapo AA, Gawande DY, Dravid SM, Buch S, Sil S. Kannan M, et al. Extracell Vesicles Circ Nucl Acids. 2022;3(2):133-149. doi: 10.20517/evcna.2022.14. Epub 2022 May 31. Extracell Vesicles Circ Nucl Acids. 2022. PMID: 36812097 Free PMC article. - HIV-1 Tat: Role in Bystander Toxicity.
Ajasin D, Eugenin EA. Ajasin D, et al. Front Cell Infect Microbiol. 2020 Feb 25;10:61. doi: 10.3389/fcimb.2020.00061. eCollection 2020. Front Cell Infect Microbiol. 2020. PMID: 32158701 Free PMC article. Review. - No reliable gene expression biomarkers of current or impending neurocognitive impairment in peripheral blood monocytes of persons living with HIV.
Quach A, Horvath S, Nemanim N, Vatakis D, Witt MD, Miller EN, Detels R, Langfelder P, Shapshak P, Singer EJ, Levine AJ. Quach A, et al. J Neurovirol. 2018 Jun;24(3):350-361. doi: 10.1007/s13365-018-0625-5. Epub 2018 Mar 26. J Neurovirol. 2018. PMID: 29582356 Free PMC article. - HIV/neuroAIDS biomarkers.
Rahimian P, He JJ. Rahimian P, et al. Prog Neurobiol. 2017 Oct;157:117-132. doi: 10.1016/j.pneurobio.2016.04.003. Epub 2016 Apr 12. Prog Neurobiol. 2017. PMID: 27084354 Free PMC article. Review. - HIV-associated neurocognitive disorder.
Clifford DB, Ances BM. Clifford DB, et al. Lancet Infect Dis. 2013 Nov;13(11):976-86. doi: 10.1016/S1473-3099(13)70269-X. Lancet Infect Dis. 2013. PMID: 24156898 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous